CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 208 filers reported holding CONMED CORP in Q4 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $491,000 | +12.6% | 5,902 | -13.2% | 0.00% | 0.0% |
| Q4 2018 | $436,000 | -17.6% | 6,798 | +1.8% | 0.00% | 0.0% |
| Q3 2018 | $529,000 | +4.3% | 6,676 | -3.6% | 0.00% | 0.0% |
| Q2 2018 | $507,000 | +3.3% | 6,924 | -10.6% | 0.00% | 0.0% |
| Q1 2018 | $491,000 | -8.4% | 7,746 | -26.3% | 0.00% | 0.0% |
| Q4 2017 | $536,000 | -4.8% | 10,511 | -2.1% | 0.00% | 0.0% |
| Q3 2017 | $563,000 | -4.9% | 10,739 | -7.5% | 0.00% | 0.0% |
| Q2 2017 | $592,000 | -3.7% | 11,610 | -16.2% | 0.00% | 0.0% |
| Q1 2017 | $615,000 | +32.5% | 13,849 | +31.8% | 0.00% | 0.0% |
| Q4 2016 | $464,000 | +32.2% | 10,506 | +19.9% | 0.00% | – |
| Q3 2016 | $351,000 | -9.8% | 8,759 | +7.4% | 0.00% | -100.0% |
| Q2 2016 | $389,000 | +25.5% | 8,157 | +10.3% | 0.00% | – |
| Q1 2016 | $310,000 | -20.7% | 7,397 | -16.6% | 0.00% | – |
| Q4 2015 | $391,000 | – | 8,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |